George K Philips MD MBBS, MPH
Professor of Medicine & Vice-Chair (Department of Medicine), Attending Physician in Genitourinary Medical Oncology (Georgetown University Hospital, Washington Cancer Institute and Lombardi Comprehensive Cancer Center)
Join to View Full Profile
3800 Reservoir Rd NwLombardi Cancer CenterWashington, DC 20007
Phone+1 202-444-2223
Fax+1 202-444-9429
Dr. Philips is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ColoradoFellowship, Hematology and Medical Oncology, 1990 - 1995
Grant Medical CollegeClass of 1986
Certifications & Licensure
DC State Medical License 2010 - 2026
MD State Medical License 2010 - 2013
VT State Medical License 1999 - 2012
CO State Medical License 1990 - 2001
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2013
Clinical Trials
- 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer Start of enrollment: 2009 Jun 01
- Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer Start of enrollment: 2013 Jul 08
Publications & Presentations
PubMed
- 6 citationsAvelumab Plus Axitinib as First-Line Therapy for Advanced Renal Cell Carcinoma: Long-Term Results from the JAVELIN Renal 100 Phase Ib Trial.James Larkin, Mototsugu Oya, Marcella Martignoni, Fiona Thistlethwaite, Paul Nathan
The Oncologist. 2023-04-06 - 9 citationsSTAG2 as a prognostic biomarker in low-grade non-muscle invasive bladder cancer.Ann Taber, Youngrok Park, Alana Lelo, Frederik Prip, Jerry Xiao
Urologic Oncology. 2021-07-01 - 90 citationsRandomized Double-Blind Phase II Study of Maintenance Pembrolizumab Versus Placebo After First-Line Chemotherapy in Patients With Metastatic Urothelial CancerMatthew D. Galsky, Amir Mortazavi, Matthew I. Milowsky, Saby George, Sumati Gupta
Journal of Clinical Oncology. 2020-04-09
Journal Articles
- STAG2 Is a Biomarker for Prediction of Recurrence and Progression in Papillary Non–Muscle-Invasive Bladder CancerCiaran Mannion, George Philips, Brent T Harris, Pritish Bhattacharyya, Jeffry Simko, Clinical Cancer Research
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
